4//SEC Filing
Herzich Paul 4
Accession 0001193125-25-308103
CIK 0001707502other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 4:17 PM ET
Size
9.1 KB
Accession
0001193125-25-308103
Insider Transaction Report
Form 4
Herzich Paul
Chief Technology Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-02+7,239→ 29,323 total - Sale
Common Stock
2025-12-03$5.11/sh−2,701$13,802→ 26,622 total - Exercise/Conversion
Restricted Stock Units
2025-12-02−7,239→ 7,239 total→ Common Stock (7,239 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").
- [F2]Includes 1,835 and 1,861 shares of the issuer's common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 30, 2025 and November 28, 2025, respectively.
- [F3]This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Mr. Herzich on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Herzich
- [F4]The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.
Documents
Issuer
Solid Biosciences Inc.
CIK 0001707502
Entity typeother
Related Parties
1- filerCIK 0001954991
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 4:17 PM ET
- Size
- 9.1 KB